However, as not only AcqRes cell lines, but also CetSens cell lines display mutations in TP53, the underlying mechanism behind the observed increased phosphorylation of Akt after cetuximab treatment in AcqRes HNSCC cell lines remains unclear. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.